Global Active Pharmaceutical Ingredients (API) Market Share, Revenue, Size and Industry Forecast till 2025

Posted on 2019-03-07 by Mark Hub in Chemicals // 0 Comments

Albany, US, 2019-Mar-07 — /EPR Network/ —The following research report is a compilation of high-end data that has been researched thoroughly to highlight the various trends prevailing across the Active Pharmaceutical Ingredients (API) market. This study is titled “Global Active Pharmaceutical Ingredients (API) Market Share, Revenue, Size and Industry Forecast till 2025”, which carefully examines several vital factors such as market share, market revenue, market dynamics and competitive scenario active in the target market for the period between 2019 and 2025.

Request for free Sample @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2099343

An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.
The EMEA average price of Active Pharmaceutical Ingredients is in the decreasing trend, from 6695 USD/MT in 2012 to 5483 USD/MT in 2017. With the situation of global economy, prices will be in decreasing trend in the following five years.

The classification of Active Pharmaceutical Ingredients includes synthetic APIs, biotech APIs, and the proportion of synthetic APIs in 2017 is about 85%, and the proportion is in decreasing trend from 2012 to 2017.
Active Pharmaceutical Ingredients is widely used in CNS, Cardiovascular, Genitourinary/Hormonal Drugs, Respiratory, Rheumatology, Diabetes, Oncology and other field. The most proportion of Active Pharmaceutical Ingredients is used for cardiovascular, and the proportion in 2017 is 21%.

The global Active Pharmaceutical Ingredients (API) market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.

This report focuses on Active Pharmaceutical Ingredients (API) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Active Pharmaceutical Ingredients (API) market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Teva
Mylan
DSM
Aurobindo Pharma
Aspen
Novartis
BASF
Pfizer
Huahai Pharmaceutical
Hisun Pharmaceutical
Sun Pharmaceutical Industries
Zhejiang Medicine
Dr. Reddys Laboratories
Zhejiang NHU
Bayer
NCPC
AbbVie
Shandong Xinhua Pharmaceutical
Northeast Pharm
Harbin Pharmaceutical
LKPC

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Synthetic APIs
Biotech APIs

Segment by Application
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others

Browse Full Report with TOC@ https://www.marketresearchhub.com/report/global-active-pharmaceutical-ingredients-api-market-research-report-2019-report.html

Table of Contents

Executive Summary
1 Active Pharmaceutical Ingredients (API) Market Overview
1.1 Product Overview and Scope of Active Pharmaceutical Ingredients (API)
1.2 Active Pharmaceutical Ingredients (API) Segment by Type
1.2.1 Global Active Pharmaceutical Ingredients (API) Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Synthetic APIs
1.2.3 Biotech APIs
1.3 Active Pharmaceutical Ingredients (API) Segment by Application
1.3.1 Active Pharmaceutical Ingredients (API) Consumption Comparison by Application (2014-2025)
1.3.2 CNS
1.3.3 Cardiovascular
1.3.4 Genitourinary/Hormonal Drugs
1.3.5 Respiratory
1.3.6 Rheumatology
1.3.7 Diabetes
1.3.8 Oncology
1.3.9 Others
1.3 Global Active Pharmaceutical Ingredients (API) Market by Region
1.3.1 Global Active Pharmaceutical Ingredients (API) Market Size Region
1.3.2 North America Status and Prospect (2014-2025)
1.3.3 Europe Status and Prospect (2014-2025)
1.3.4 China Status and Prospect (2014-2025)
1.3.5 Japan Status and Prospect (2014-2025)
1.3.6 Southeast Asia Status and Prospect (2014-2025)
1.3.7 India Status and Prospect (2014-2025)
1.4 Global Active Pharmaceutical Ingredients (API) Market Size
1.4.1 Global Active Pharmaceutical Ingredients (API) Revenue (2014-2025)
1.4.2 Global Active Pharmaceutical Ingredients (API) Production (2014-2025)

2 Global Active Pharmaceutical Ingredients (API) Market Competition by Manufacturers
2.1 Global Active Pharmaceutical Ingredients (API) Production Market Share by Manufacturers (2014-2019)
2.2 Global Active Pharmaceutical Ingredients (API) Revenue Share by Manufacturers (2014-2019)
2.3 Global Active Pharmaceutical Ingredients (API) Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Active Pharmaceutical Ingredients (API) Production Sites, Area Served, Product Types
2.5 Active Pharmaceutical Ingredients (API) Market Competitive Situation and Trends
2.5.1 Active Pharmaceutical Ingredients (API) Market Concentration Rate
2.5.2 Active Pharmaceutical Ingredients (API) Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Active Pharmaceutical Ingredients (API) Production Market Share by Regions
3.1 Global Active Pharmaceutical Ingredients (API) Production Market Share by Regions
3.2 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Regions (2014-2019)
3.3 Global Active Pharmaceutical Ingredients (API) Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Active Pharmaceutical Ingredients (API) Production
3.4.1 North America Active Pharmaceutical Ingredients (API) Production Growth Rate (2014-2019)
3.4.2 North America Active Pharmaceutical Ingredients (API) Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Active Pharmaceutical Ingredients (API) Production
3.5.1 Europe Active Pharmaceutical Ingredients (API) Production Growth Rate (2014-2019)
3.5.2 Europe Active Pharmaceutical Ingredients (API) Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Active Pharmaceutical Ingredients (API) Production (2014-2019)
3.6.1 China Active Pharmaceutical Ingredients (API) Production Growth Rate (2014-2019)
3.6.2 China Active Pharmaceutical Ingredients (API) Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Active Pharmaceutical Ingredients (API) Production (2014-2019)
3.7.1 Japan Active Pharmaceutical Ingredients (API) Production Growth Rate (2014-2019)
3.7.2 Japan Active Pharmaceutical Ingredients (API) Production, Revenue, Price and Gross Margin (2014-2019)

Continue…@@$

Enquire about this Report – https://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=2099343

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of chemical market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Matched content

Editor’s pick